$4.83 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 104 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 49.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | NUVALENT INC | $595,332,695 | +58.3% | 19,991,024 | +3.4% | 12.32% | +64.7% | |
| GLAUKOS CORPnote 2.750% 6/1 | $312,639,806 | -12.1% | 271,752,000 | 0.0% | 6.47% | -8.6% | ||
| Buy | INVITAE CORPnote 2.000% 9/0 | $190,842,634 | +17.6% | 241,873,000 | +16.9% | 3.95% | +22.3% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $180,678,560 | +12.5% | 1,512,714 | 0.0% | 3.74% | +16.9% | |
| New | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $165,397,613 | – | 88,657,000 | +100.0% | 3.42% | – | |
| AHCO | Sell | ADAPTHEALTH CORP | $146,589,287 | -5.1% | 7,626,914 | -7.3% | 3.03% | -1.3% |
| IONIS PHARMACEUTICALS INCnote 4/0 | $118,341,522 | -7.9% | 127,800,000 | 0.0% | 2.45% | -4.2% | ||
| TABULA RASA HEALTHCARE INCnote 1.750% 2/1 | $114,624,311 | -0.8% | 144,516,000 | 0.0% | 2.37% | +3.2% | ||
| New | BROOKDALE SR LIVING INCnote 2.000%10/1 | $112,249,612 | – | 145,955,000 | +100.0% | 2.32% | – | |
| VTRS | Sell | VIATRIS INC | $111,300,000 | +22.4% | 10,000,000 | -6.3% | 2.30% | +27.3% |
| CPRX | Buy | CATALYST PHARMACEUTICALS INC | $109,450,733 | +74.2% | 5,884,448 | +20.2% | 2.27% | +81.3% |
| Buy | NATERA INCnote 2.250% 5/0 | $108,055,189 | +110.2% | 84,913,000 | +125.6% | 2.24% | +118.7% | |
| New | AMYLYX PHARMACEUTICALS INC | $99,506,350 | – | 2,693,000 | +100.0% | 2.06% | – | |
| Buy | INSMED INCnote 1.750% 1/1 | $95,820,127 | +30.9% | 102,700,000 | +36.9% | 1.98% | +36.1% | |
| Buy | INTERCEPT PHARMACEUTICALS INnote 3.500% 2/1 | $95,235,195 | +17.4% | 98,354,000 | +25.3% | 1.97% | +22.1% | |
| NUVASIVE INCnote 1.000% 6/0 | $95,183,765 | +1.6% | 96,966,000 | 0.0% | 1.97% | +5.6% | ||
| AMED | Buy | AMEDISYS INC | $94,908,123 | +172.6% | 1,136,080 | +215.8% | 1.96% | +183.5% |
| SBTX | New | ARS PHARMACEUTICALS INC | $94,494,717 | – | 11,077,927 | +100.0% | 1.96% | – |
| APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $79,433,341 | -19.9% | 51,885,000 | 0.0% | 1.64% | -16.7% | ||
| New | OAK STR HEALTH INCnote 3/1 | $75,994,000 | – | 100,000,000 | +100.0% | 1.57% | – | |
| SILK | Sell | SILK RD MED INC | $73,812,424 | -35.3% | 1,396,640 | -44.9% | 1.53% | -32.7% |
| PACIRA BIOSCIENCES INCnote 0.750% 8/0 | $73,553,424 | -8.9% | 81,600,000 | 0.0% | 1.52% | -5.3% | ||
| ISEE | Sell | IVERIC BIO INC | $73,326,081 | -3.7% | 3,424,852 | -19.3% | 1.52% | +0.1% |
| ACCOLADE INCnote 0.500% 4/0 | $73,303,650 | -7.3% | 105,000,000 | 0.0% | 1.52% | -3.6% | ||
| LRMR | LARIMAR THERAPEUTICS INC | $69,967,804 | +29.1% | 16,941,357 | 0.0% | 1.45% | +34.2% | |
| CMAX | CAREMAX INC | $57,892,979 | -48.5% | 15,861,090 | 0.0% | 1.20% | -46.5% | |
| Buy | NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0 | $56,746,595 | +16.6% | 70,204,000 | +21.9% | 1.18% | +21.3% | |
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $56,418,464 | +0.6% | 57,791,000 | 0.0% | 1.17% | +4.6% | ||
| GUARDANT HEALTH INCnote 11/1 | $55,784,615 | -14.2% | 89,036,000 | 0.0% | 1.16% | -10.8% | ||
| CNC | Buy | CENTENE CORP DEL | $46,335,650 | +28.3% | 565,000 | +21.8% | 0.96% | +33.4% |
| Buy | HILLEVAX INC | $45,072,310 | -0.6% | 2,694,101 | +1.5% | 0.93% | +3.3% | |
| PHR | Buy | PHREESIA INC | $44,214,406 | +27.8% | 1,366,329 | +0.6% | 0.92% | +32.8% |
| LIVONGO HEALTH INCnote 0.875% 6/0 | $43,769,000 | +4.3% | 50,000,000 | 0.0% | 0.91% | +8.4% | ||
| Sell | ALPHATEC HLDGS INCnote 0.750% 8/0 | $43,668,321 | -46.4% | 48,050,000 | -52.0% | 0.90% | -44.2% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $39,630,533 | -7.2% | 2,032,335 | 0.0% | 0.82% | -3.5% | |
| Buy | ENHABIT INC | $39,427,360 | +93.1% | 2,996,000 | +106.0% | 0.82% | +101.0% | |
| 1LIFE HEALTHCARE INCnote 3.000% 6/1 | $39,151,240 | -0.6% | 40,599,000 | 0.0% | 0.81% | +3.3% | ||
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $38,503,847 | -16.5% | 2,349,228 | -5.7% | 0.80% | -13.2% |
| MRUS | Sell | MERUS N V | $36,825,376 | -27.1% | 2,380,438 | -5.6% | 0.76% | -24.2% |
| ANAB | Sell | ANAPTYSBIO INC | $36,004,988 | -3.8% | 1,161,826 | -20.8% | 0.74% | 0.0% |
| EWTX | EDGEWISE THERAPEUTICS INC | $35,162,245 | -9.1% | 3,933,137 | 0.0% | 0.73% | -5.5% | |
| BKD | Buy | BROOKDALE SR LIVING INC | $34,615,447 | -6.7% | 12,679,651 | +45.9% | 0.72% | -3.0% |
| COGT | COGENT BIOSCIENCES INC | $34,290,948 | -22.5% | 2,966,345 | 0.0% | 0.71% | -19.4% | |
| PCVX | New | VAXCYTE INC | $33,565,000 | – | 700,000 | +100.0% | 0.70% | – |
| IDYA | IDEAYA BIOSCIENCES INC | $31,681,721 | +21.8% | 1,743,628 | 0.0% | 0.66% | +26.6% | |
| IMGN | Sell | IMMUNOGEN INC | $31,537,237 | -52.0% | 6,358,314 | -53.7% | 0.65% | -50.0% |
| PTC THERAPEUTICS INCnote 1.500% 9/1 | $31,357,440 | -16.5% | 32,000,000 | 0.0% | 0.65% | -13.2% | ||
| KURA | Buy | KURA ONCOLOGY INC | $29,573,030 | -2.4% | 2,383,000 | +7.4% | 0.61% | +1.5% |
| BLU | Buy | BELLUS HEALTH INC NEW | $29,435,820 | -9.5% | 3,581,000 | +16.2% | 0.61% | -6.0% |
| TERN | Buy | TERNS PHARMACEUTICALS INC | $29,026,102 | +165.0% | 2,851,287 | +53.3% | 0.60% | +175.7% |
| New | NEWAMSTERDAM PHARMA COMPANYordinary shares | $27,034,169 | – | 2,480,199 | +100.0% | 0.56% | – | |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $26,868,330 | +15.3% | 1,033,000 | +26.4% | 0.56% | +19.8% |
| HEALTH CATALYST INCnote 2.500% 4/1 | $26,015,100 | +1.9% | 30,000,000 | 0.0% | 0.54% | +6.1% | ||
| Sell | VIGIL NEUROSCIENCE INC | $25,650,125 | +42.9% | 2,052,010 | -0.1% | 0.53% | +48.7% | |
| EOLS | Sell | EVOLUS INC | $24,925,690 | -42.6% | 3,319,000 | -38.4% | 0.52% | -40.3% |
| OMI | New | OWENS & MINOR INC NEW | $23,025,870 | – | 1,179,000 | +100.0% | 0.48% | – |
| RAIN | New | RAIN ONCOLOGY INC | $22,370,088 | – | 2,796,261 | +100.0% | 0.46% | – |
| DNLI | New | DENALI THERAPEUTICS INC | $22,248,000 | – | 800,000 | +100.0% | 0.46% | – |
| RVMD | Sell | REVOLUTION MEDICINES INC | $21,237,602 | -62.8% | 891,587 | -69.2% | 0.44% | -61.2% |
| DAWN | Sell | DAY ONE BIOPHARMACEUTICALS I | $20,745,990 | +0.4% | 964,033 | -6.6% | 0.43% | +4.4% |
| TARS | TARSUS PHARMACEUTICALS INC | $19,412,977 | -14.4% | 1,324,214 | 0.0% | 0.40% | -10.9% | |
| APEN | APOLLO ENDOSURGERY INC | $17,447,500 | +80.9% | 1,750,000 | 0.0% | 0.36% | +88.0% | |
| XERIS BIOPHARMA HOLDINGS INCnote 5.000% 7/1 | $17,094,600 | -1.7% | 18,000,000 | 0.0% | 0.35% | +2.3% | ||
| New | PRIME MEDICINE INC | $16,449,134 | – | 885,314 | +100.0% | 0.34% | – | |
| DA32 LIFE SCNCE TEC ACQSTN C | $15,992,000 | +2.7% | 1,600,000 | 0.0% | 0.33% | +6.8% | ||
| KRYS | KRYSTAL BIOTECH INC | $13,863,500 | +13.7% | 175,000 | 0.0% | 0.29% | +18.1% | |
| INSM | Sell | INSMED INC | $13,269,637 | -35.9% | 664,146 | -30.9% | 0.28% | -33.3% |
| OMIC | Sell | SINGULAR GENOMICS SYSTEMS IN | $12,966,251 | -26.7% | 6,450,871 | -8.9% | 0.27% | -23.9% |
| ATEC | Sell | ALPHATEC HLDGS INC | $12,927,869 | -41.6% | 1,046,791 | -58.7% | 0.27% | -39.2% |
| NUVB | Buy | NUVATION BIO INC | $11,241,331 | +1943.9% | 5,854,860 | +2286.2% | 0.23% | +2018.2% |
| PCRX | PACIRA BIOSCIENCES INC | $11,274,120 | -27.4% | 292,000 | 0.0% | 0.23% | -24.6% | |
| KZR | New | KEZAR LIFE SCIENCES INC | $10,067,200 | – | 1,430,000 | +100.0% | 0.21% | – |
| ALEC | ALECTOR INC | $9,739,422 | -2.4% | 1,055,192 | 0.0% | 0.20% | +1.5% | |
| CSTL | New | CASTLE BIOSCIENCES INC | $6,406,058 | – | 272,135 | +100.0% | 0.13% | – |
| THE ONCOLOGY INSTITUTE INC | $5,544,086 | -64.4% | 3,360,052 | 0.0% | 0.12% | -62.9% | ||
| NEOGENOMICS INCnote 1.250% 5/0 | $5,471,570 | -1.8% | 6,500,000 | 0.0% | 0.11% | +1.8% | ||
| FHTX | FOGHORN THERAPEUTICS INC | $4,960,610 | -25.6% | 777,525 | 0.0% | 0.10% | -22.6% | |
| CABA | CABALETTA BIO INC | $4,294,331 | +1322.0% | 464,252 | 0.0% | 0.09% | +1383.3% | |
| AFIB | ACUTUS MED INC | $3,049,417 | +30.7% | 2,651,667 | 0.0% | 0.06% | +37.0% | |
| ANNX | ANNEXON INC | $3,018,830 | -16.4% | 583,913 | 0.0% | 0.06% | -13.9% | |
| New | ABEONA THERAPEUTICS INC | $2,678,260 | – | 869,565 | +100.0% | 0.06% | – | |
| Sell | SEMA4 HOLDINGS CORP | $2,650,991 | -82.2% | 10,049,244 | -40.8% | 0.06% | -81.4% | |
| GRAY | GRAYBUG VISION INC | $2,640,857 | -46.8% | 5,281,713 | 0.0% | 0.06% | -44.4% | |
| NYXOAH S A | $2,271,757 | -20.8% | 455,262 | 0.0% | 0.05% | -17.5% | ||
| ROIVANT SCIENCES LTD*w exp 09/30/202 | $1,940,000 | +397.4% | 1,000,000 | 0.0% | 0.04% | +400.0% | ||
| ORTX | Sell | ORCHARD THERAPEUTICS PLCspon ads | $1,172,993 | -66.2% | 3,161,707 | -54.5% | 0.02% | -65.2% |
| Sell | PEPGEN INC | $802,320 | -88.1% | 60,009 | -91.9% | 0.02% | -87.4% | |
| ONCR | Sell | ONCORUS INC | $642,416 | -76.0% | 2,536,186 | -19.5% | 0.01% | -75.5% |
| SIEN | New | SIENTRA INC | $543,762 | – | 2,679,950 | +100.0% | 0.01% | – |
| CMAXW | CAREMAX INC*w exp 06/08/202 | $350,650 | -72.2% | 672,000 | 0.0% | 0.01% | -72.0% | |
| MDVL | MEDAVAIL HOLDINGS INC | $250,820 | -61.4% | 836,626 | 0.0% | 0.01% | -61.5% | |
| BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $190,667 | -69.0% | 733,333 | 0.0% | 0.00% | -66.7% | |
| THE ONCOLOGY INSTITUTE INC*w exp 11/15/202 | $137,625 | -80.1% | 1,250,000 | 0.0% | 0.00% | -78.6% | ||
| QSIAW | QUANTUM SI INC*w exp 06/10/202 | $83,333 | -52.9% | 333,333 | 0.0% | 0.00% | -50.0% | |
| New | NEWAMSTERDAM PHARMA COMPANY*w exp 11/22/202 | $80,567 | – | 92,787 | +100.0% | 0.00% | – | |
| New | PEAK BIO INC*w exp 10/26/202 | $73,406 | – | 362,500 | +100.0% | 0.00% | – | |
| SNRHW | SENIOR CONNECT ACQUISITN COR*w exp 12/31/202 | $30,050 | +200.5% | 500,000 | 0.0% | 0.00% | – | |
| SOMALOGIC INC*w exp 08/31/202 | $48,000 | -9.4% | 120,000 | 0.0% | 0.00% | 0.0% | ||
| MTACW | MEDTECH ACQUISITION CORP*w exp 12/22/202 | $25,000 | +25.0% | 333,333 | 0.0% | 0.00% | – | |
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $18,533 | +42.6% | 333,333 | 0.0% | 0.00% | – | |
| MTACU | MEDTECH ACQUISITION CORPunit 12/18/2025 | $10 | – | 1 | 0.0% | 0.00% | – | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $24,083 | -27.0% | 166,666 | 0.0% | 0.00% | -100.0% | |
| SURROZEN INC*w exp 08/01/203 | $9,183 | -70.4% | 166,666 | 0.0% | 0.00% | -100.0% | ||
| EUCRU | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $10 | – | 1 | 0.0% | 0.00% | – | |
| WINT | Exit | WINDTREE THERAPEUTICS INC | $0 | – | -20,148 | -100.0% | 0.00% | – |
| SRSAW | Exit | SARISSA CAPITAL ACQUISITN CO*w exp 10/23/202 | $0 | – | -333,333 | -100.0% | 0.00% | – |
| TMPMW | Exit | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $0 | – | -250,000 | -100.0% | 0.00% | – |
| OHPAW | Exit | ORION ACQUISITION CORP*w exp 02/19/202 | $0 | – | -125,000 | -100.0% | 0.00% | – |
| REVHW | Exit | REVOLUTION HEALTHCAR AQ CORP*w exp 12/31/202 | $0 | – | -200,000 | -100.0% | 0.00% | – |
| GKOS | Exit | GLAUKOS CORP | $0 | – | 0 | +100.0% | 0.00% | – |
| SRSAU | Exit | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $0 | – | -1 | -100.0% | 0.00% | – |
| IGNYW | Exit | IGNYTE ACQUISITION CORP*w exp 01/05/202 | $0 | – | -362,500 | -100.0% | -0.00% | – |
| DCTH | Exit | DELCATH SYS INC | $0 | – | -486,068 | -100.0% | -0.03% | – |
| PROF | Exit | PROFOUND MED CORP | $0 | – | -732,543 | -100.0% | -0.06% | – |
| KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -250,000 | -100.0% | -0.06% | – |
| QSI | Exit | QUANTUM SI INC | $0 | – | -1,400,000 | -100.0% | -0.08% | – |
| HOWL | Exit | WEREWOLF THERAPEUTICS INC | $0 | – | -958,125 | -100.0% | -0.09% | – |
| OHPA | Exit | ORION ACQUISITION CORP | $0 | – | -500,000 | -100.0% | -0.10% | – |
| INZY | Exit | INOZYME PHARMA INC | $0 | – | -2,090,436 | -100.0% | -0.11% | – |
| IGNY | Exit | IGNYTE ACQUISITION CORP | $0 | – | -725,000 | -100.0% | -0.14% | – |
| TMPM | Exit | TURMERIC ACQUISITION CORPcl a | $0 | – | -750,000 | -100.0% | -0.15% | – |
| PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -1,000,000 | -100.0% | -0.15% | – |
| PHVS | Exit | PHARVARIS N V | $0 | – | -1,104,552 | -100.0% | -0.17% | – |
| REVH | Exit | REVOLUTION HEALTHCAR AQ CORP | $0 | – | -1,000,000 | -100.0% | -0.20% | – |
| SNRH | Exit | SENIOR CONNECT ACQUISITN COR | $0 | – | -1,000,000 | -100.0% | -0.20% | – |
| MTAC | Exit | MEDTECH ACQUISITION CORP | $0 | – | -999,999 | -100.0% | -0.20% | – |
| SRSA | Exit | SARISSA CAPITAL ACQUISITN COcl a | $0 | – | -999,999 | -100.0% | -0.20% | – |
| EUCR | Exit | EUCRATES BIOMEDICAL ACQUISIT | $0 | – | -999,999 | -100.0% | -0.20% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -484,947 | -100.0% | -0.22% | – |
| ADCT | Exit | ADC THERAPEUTICS SA | $0 | – | -2,390,297 | -100.0% | -0.23% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -2,021,000 | -100.0% | -0.23% | – |
| Exit | AN2 THERAPEUTICS INC | $0 | – | -716,538 | -100.0% | -0.25% | – | |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -870,000 | -100.0% | -0.28% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -2,677,500 | -100.0% | -0.32% | – |
| ISEE | Exit | IVERIC BIO INCcall | $0 | – | -1,000,000 | -100.0% | -0.36% | – |
| Exit | NOVAVAX INCnote 3.750% 2/0 | $0 | – | -25,000,000 | -100.0% | -0.48% | – | |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -75,000 | -100.0% | -0.49% | – |
| VERV | Exit | VERVE THERAPEUTICS INC | $0 | – | -750,000 | -100.0% | -0.51% | – |
| PHAT | Exit | PHATHOM PHARMACEUTICALS INC | $0 | – | -2,414,897 | -100.0% | -0.53% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -813,112 | -100.0% | -0.78% | – |
| Exit | NEVRO CORPnote 2.750% 4/0 | $0 | – | -42,000,000 | -100.0% | -0.79% | – | |
| Exit | OAK STR HEALTH INCnote 3/1 | $0 | – | -68,000,000 | -100.0% | -1.04% | – | |
| LUNG | Exit | PULMONX CORP | $0 | – | -3,720,901 | -100.0% | -1.23% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -4,855,005 | -100.0% | -1.46% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -330,000 | -100.0% | -1.75% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -1,537,539 | -100.0% | -1.89% | – |
| Exit | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $0 | – | -88,657,000 | -100.0% | -2.95% | – | |
| Exit | AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $0 | – | -174,372,000 | -100.0% | -3.40% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.